Barbara Forte

1,4,5,6-Tetrahydropyrrolo[3,4-<i>c</i>]pyrazoles:  Identification of a Potent Aurora Kinase Inhibitor with a Favorable Antitumor Kinase Inhibition Profile

Daniele Fancelli, Jürgen Moll, Mario Varasi et al. · Journal of Medicinal Chemistry · 2006 · 189 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Chemoprevention Strategy +14

Potent and Selective Aurora Inhibitors Identified by the Expansion of a Novel Scaffold for Protein Kinase Inhibition

Daniele Fancelli, Daniela Berta, Simona Bindi et al. · Journal of Medicinal Chemistry · 2005 · 143 citations · Full text

Molecular Biology, Chemical Biology, Pharmaceutical Chemistry +18

Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1<i>H</i>-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy

Gianluca Papeo, Helena Posteri, Daniela Borghi et al. · Journal of Medicinal Chemistry · 2015 · 139 citations · Full text

Cancer Therapy, Drug Target, Pharmacotherapy +18

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis

Beatriz Baragaña, Barbara Forte, Ryan Choi et al. · Proceedings of the National Academy of Sciences · 2019 · 132 citations · Full text

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor

Italo Beria, R Bossi, Maria Gabriella Brasca et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 104 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +9